117 related articles for article (PubMed ID: 23674206)
1. MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.
Menichetti L; Kusmic C; Panetta D; Arosio D; Petroni D; Matteucci M; Salvadori PA; Casagrande C; L'Abbate A; Manzoni L
Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1265-74. PubMed ID: 23674206
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
3. [
Bentsen S; Jensen JK; Christensen E; Petersen LR; Grandjean CE; Follin B; Madsen JS; Christensen C; Clemmensen A; Binderup T; Hasbak P; Ripa RS; Kjaer A
J Nucl Cardiol; 2023 Oct; 30(5):2073-2084. PubMed ID: 37127725
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, preclinical, and initial clinical evaluation of integrin α
Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
[TBL] [Abstract][Full Text] [Related]
5. Integrin α
Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J
Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041
[TBL] [Abstract][Full Text] [Related]
6. Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin α
Liu K; Jiang T; Rao W; Chen B; Yin X; Xu P; Hu S
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1544-1557. PubMed ID: 38276986
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Myocardial α
Nammas W; Paunonen C; Teuho J; Siekkinen R; Luoto P; Käkelä M; Hietanen A; Viljanen T; Dietz M; Prior JO; Li XG; Roivainen A; Knuuti J; Saraste A
J Nucl Med; 2024 Jan; 65(1):132-138. PubMed ID: 37973184
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a dual-receptor targeted tracer [
Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
[TBL] [Abstract][Full Text] [Related]
9. In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD.
Dimastromatteo J; Riou LM; Ahmadi M; Pons G; Pellegrini E; Broisat A; Sancey L; Gavrilina T; Boturyn D; Dumy P; Fagret D; Ghezzi C
J Nucl Cardiol; 2010 Jun; 17(3):435-43. PubMed ID: 20087797
[TBL] [Abstract][Full Text] [Related]
10. Click-Chemistry (CuAAC) Trimerization of an α
Quigley NG; Tomassi S; Di Leva FS; Di Maro S; Richter F; Steiger K; Kossatz S; Marinelli L; Notni J
Chembiochem; 2020 Oct; 21(19):2836-2843. PubMed ID: 32359011
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Quality Control, and Bench-to-Bed Translation of a New [
Chakraborty S; Chatterjee S; Chakravarty R; Sarma HD; Nanabala R; Goswami D; Joy A; Pillai MRA
Cancer Biother Radiopharm; 2024 Feb; 39(1):92-101. PubMed ID: 38335449
[No Abstract] [Full Text] [Related]
12. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang X; Xiong Z; Wu Y; Cai W; Tseng JR; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):113-21. PubMed ID: 16391195
[TBL] [Abstract][Full Text] [Related]
13. First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies.
Chin FT; Shen B; Liu S; Berganos RA; Chang E; Mittra E; Chen X; Gambhir SS
Mol Imaging Biol; 2012 Feb; 14(1):88-95. PubMed ID: 21400112
[TBL] [Abstract][Full Text] [Related]
14. Natural History of Myocardial α
Dietz M; Kamani CH; Bousige C; Dunet V; Delage J; Rubimbura V; Nicod Lalonde M; Treglia G; Schaefer N; Nammas W; Saraste A; Knuuti J; Mewton N; Prior JO
J Nucl Med; 2024 May; ():. PubMed ID: 38724280
[TBL] [Abstract][Full Text] [Related]
15. Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI.
Rischpler C; Nekolla SG; Kossmann H; Dirschinger RJ; Schottelius M; Hyafil F; Wester HJ; Laugwitz KL; Schwaiger M
J Nucl Cardiol; 2016 Feb; 23(1):131-3. PubMed ID: 26667813
[No Abstract] [Full Text] [Related]
16. Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression.
Golestani R; Mirfeizi L; Zeebregts CJ; Westra J; de Haas HJ; Glaudemans AW; Koole M; Luurtsema G; Tio RA; Dierckx RA; Boersma HH; Elsinga PH; Slart RH
J Nucl Cardiol; 2015 Dec; 22(6):1179-86. PubMed ID: 25698472
[TBL] [Abstract][Full Text] [Related]
17. (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.
Yu C; Pan D; Mi B; Xu Y; Lang L; Niu G; Yang M; Wan W; Chen X
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2021-8. PubMed ID: 26121930
[TBL] [Abstract][Full Text] [Related]
18. Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.
Saraste A; Laitinen I; Weidl E; Wildgruber M; Weber AW; Nekolla SG; Hölzlwimmer G; Esposito I; Walch A; Leppänen P; Lisinen I; Luppa PB; Ylä-Herttuala S; Wester HJ; Knuuti J; Schwaiger M
J Nucl Cardiol; 2012 Aug; 19(4):775-84. PubMed ID: 22527796
[TBL] [Abstract][Full Text] [Related]
19. One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for
Hungnes IN; Al-Salemee F; Gawne PJ; Eykyn T; Atkinson RA; Terry SYA; Clarke F; Blower PJ; Pringle PG; Ma MT
Dalton Trans; 2021 Nov; 50(44):16156-16165. PubMed ID: 34704995
[TBL] [Abstract][Full Text] [Related]
20. In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis.
Jenkins WS; Vesey AT; Vickers A; Neale A; Moles C; Connell M; Joshi NV; Lucatelli C; Fletcher AM; Spratt JC; Mirsadraee S; van Beek EJ; Rudd JH; Newby DE; Dweck MR
Heart; 2019 Dec; 105(24):1868-1875. PubMed ID: 31422361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
